AI English summary of an SEC filing — figures as filed
HCA Healthcare HCAThe company said revenues for Q3 2026 rose to $19.849 billion from $19.161 billion a year earlier. Net income attributable to HCA Healthcare, Inc. was $1.579 billion ($7.27 per diluted share), compared with $1.643 billion ($6.96 per share) a year earlier.
Key points
AI summaryThe company said revenues for Q3 2026 rose to $19.849 billion from $19.161 billion a year earlier. Net income attributable to HCA Healthcare, Inc. was $1.579 billion ($7.27 per diluted share), compared with $1.643 billion ($6.96 per share) a year earlier.
HCA said uninsured admissions for Q3 2026 rose 27.2% on a consolidated basis and 27.4% on a same facility basis. The company attributed the increase to continued effects of the expiration of the enhanced premium tax credits at the end of 2025 and administrative reforms, and said Medicaid conversions declined.
The company said its estimated total uncompensated care cost, comprising charity care, uninsured discounts and implicit price concessions, was $1.477 billion for Q3 2026, compared with $1.188 billion a year earlier. For the 9-month period ended 2026, the figure was $4.174 billion, versus $3.359 billion a year earlier.
The company said operating cash flow for the 9 months ended 2026 was $8.810 billion, lower than $10.277 billion a year earlier. Over the same period, it reported net debt issuance of $3.788 billion and share repurchases of $6.605 billion. Total debt as of September 30, 2026 was $50.493 billion.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
HCA QQ3 2026 Revenue, Net Income and Diluted EPS
The company said revenues for Q3 2026 rose to $19.849 billion from $19.161 billion a year earlier. Net income attributable to HCA Healthcare, Inc. was $1.579 billion ($7.27 per diluted share), compared with $1.643 billion ($6.96 per share) a year earlier.
Source · Based on the MD&A text of the filing
Rising Uninsured Admissions and EPTC Expiration Impact
HCA said uninsured admissions for Q3 2026 rose 27.2% on a consolidated basis and 27.4% on a same facility basis. The company attributed the increase to continued effects of the expiration of the enhanced premium tax credits at the end of 2025 and administrative reforms, and said Medicaid conversions declined.
Source · Based on the MD&A text of the filing
Total Uncompensated Care Costs for Q3
The company said its estimated total uncompensated care cost, comprising charity care, uninsured discounts and implicit price concessions, was $1.477 billion for Q3 2026, compared with $1.188 billion a year earlier. For the 9-month period ended 2026, the figure was $4.174 billion, versus $3.359 billion a year earlier.
Source · Based on the MD&A text of the filing
9-Month 2026 Cash Flow, Debt and Share Repurchases
The company said operating cash flow for the 9 months ended 2026 was $8.810 billion, lower than $10.277 billion a year earlier. Over the same period, it reported net debt issuance of $3.788 billion and share repurchases of $6.605 billion. Total debt as of September 30, 2026 was $50.493 billion.
Source · Based on the MD&A text of the filing
Structured SEC financial data for this filing is not available yet. Please check the figures in the SEC filing.
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…